Asia Pacific Pharma Market Exhibiting Exhilarant Prospective

Asia-Pacific region remains bright, and the Pharma industry is projected to grow at a CAGR of over 10% during 2012-2015, says RNCOS in its recent research.

NOIDA, India (prHWY.com) July 15, 2012 - Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In recent years, healthcare demand among the region's populations have increased and its low operating costs continue to attract pharmaceutical companies. For instance, GSK, Pfizer along with other pharma companies have opened their manufacturing facilities in South Korea and various other countries of the region. It is also emerging as a powerhouse of pharmaceutical Research & Development (R&D) facilitated by the availability of a vast patient population, quality data, lower costs and skilled manpower. In future, the Asian-Pacific pharmaceutical market is projected to grow at a CAGR of around 10% during 2012-2015.

Research Analysis & Highlights

The report, "Asia Pacific Pharma Sector Analysis" by RNCOS, which is spread over 160 pages provides an in-depth research and rational analysis of the current status and expected position of the Pharma Market in Asia Pacific. It thoroughly examines all prominent emerging trends and drivers, which are fueling growth to the industry's development. It will provide indispensable information to clients in understanding the market dynamics and to get an insight of the industry at the micro level.

The report presents information on the key competitors in each country in the Asian-Pacific region along with their business details and areas of expertise. It also presents a highly concentrated structure of the market, along with the top players dominating the market. A segment level analysis of the industry along with emerging trends that may shape up with the betterment of economic conditions is also presented in the report. The research will help consultants, industry analysts, and vendors to get an in-depth knowledge of the current, past, and future performance of the industry.

Some of the report's key highlights include:

- China Pharma Market Thriving Unprecedentedly
- South Korea pharma Market to witness double-digit growth
- Pharmaceutical industry in India Holds Immense Opportunities for Growth
- Booming Medical Tourism Market in Asia-Pacific

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM226.htm

Some of our Related Reports are:

- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally(http://www.rncos.com/Report/IM081.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: global leading drugs

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code